Tigermed

New page exploration in action with #Tigermed #Vaccine research is unique in its ability to have a widespread impact on global health. Now more than ever, vaccine development requires a more innovative and efficient approach. Our vaccine service scope covers vaccine clinical #design, #monitoring, data #statistics and biological #testing, we work closely with you to develop personalized roadmaps for your vaccine study and aim to maximize efficiency, anticipate challenges, and mitigate risk. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/gm_Wkqir

What an incredible week at #DIA 2024! From June 16th to 20th, Tigermed was immersed in an environment brimming with #innovation, #collaboration, and #forward-thinking discussions, presenting our pioneering solutions and demonstrating our unwavering commitment to excellence in clinical trials.   A heartfelt thank you to everyone who visited our booth. Stay connected with Tigermed for more exciting updates and developments as we continue to shape the future of #healthcare together!

Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Quality, reaffirming our commitment to innovative service and global health.   We are pleased to invite Katie Ponce to share her experience on Quality First is not only a slogan but also a working method and code of conduct. "I joined the Tigermed in early March and attended the team's first meeting. Colleagues emphasized the importance of choosing appropriate methods in our work and shared the viewpoint that 'even if the statistical methods we choose cannot prove the success of the research product, these methods must be of high quality.' Therefore, I believe that ‘Quality’ not only means the success of the trial, but also ensures the reliability, rigor, and interpretability of the methods and results. Only high-quality work can produce high-quality results, and I am delighted to be part of the biostatistics team. Here, I see the team improving the quality of statistical work through various means, which fills me with confidence in focusing on research work related to oncology compounds and contributing to the biostatistics work in clinical trials."

We are thrilled to be heading back to the beautiful city of San Diego for #DIA2024!   Each year DIA brings together professionals across all sectors of the life science community, with a common goal and passion for improving health outcomes for patients across the globe. We are excited to have the opportunity to reconnect with friends, colleagues and partners as well as to showcase what Tigermed is doing to enhance health and drive medical innovation for all!   Whether you’re heading to DIA as well or just in the San Diego area, let us know or connect with Cooper Anderson at Tigermed’s booth #2021.

As the largest and most comprehensive biotech event, #BIO #International #Convention brings together over 18,500 industry leaders. Join Tigermed at the SWISS BIOTECH Pavilion, Booth #2111, from June 3-6. We're here to connect with industry leaders, innovators, and professionals from all over the world, and excited to explore potential collaborations and discover how we can work together to advance the future of #biotechnology. 

What a fantastic day for team Tigermed at ASCO Annual Meeting 2024! It's been great to meet our partners and customers and have in-depth discussion on delivering clinical solutions for oncology breakthroughs. #asco #tigermed #clinicaltrials #clinicalresearch

Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Human #Life, reaffirming our commitment to innovative service and global health. We are pleased to invite Julian Nathanael to share his experience on how to shape his #career and personal #growth in the Clinical Operations department and explore the meaning of "Human Life" together. “‘Human-Life’ has become an important principle in our work, which not only means that we value communication with every teammate around us, but also represents that we learn from each other and improve through one exchange to provide high-quality services for the benefit of more patients. Working in clinical research presents various challenges, such as data inconsistencies, protocol deviations, and participant recruitment difficulties. However, ‘Human-Life’ is our key to overcoming these challenges. For example, when we encountered a significant amount of unencoded data, we collaborated with the project team, investigators, and site staff to discuss potential causes and solutions. We utilize all available resources, both from the site staff and CRAs, for the swift completion of data entry and verification. This is because Tigermed prides itself in placing people first, ensuring the accuracy of our data, and providing high-quality clinical trial services to benefit patients, as we remain steadfast in our commitment to give primacy to 'Human-Life’ above all else.”

Join Alice Lin, Director of DCT Solutions at Tigermed, as she discusses the transformative impact of technology in decentralized clinical trials. Alice shares insights on enhancing patient recruitment and retention, and how Tigermed’s patient-centric approach is paving the way for a more accessible and flexible clinical trial experience. Learn about innovative digital solutions and technologies that are reshaping the clinical trial landscape, and Tigermed’s pioneering role in driving this evolution. Don't miss this engaging discussion! #DCT #DecentralizedClinicalTrials #MedTech #RemoteMonitoring https://lnkd.in/gZREFT4J

ASCO Annual Meeting is just one week away and we are excited to welcome and meet you at Tigermed booth 13147! This year we bring our medical scientists, oncology experts and global leaderships from US, Europe and APAC and looking forward to discussing with you on how we can support/accelerate your oncology clinical research. Schedule a meeting with us at ASCO: https://lnkd.in/g-4CCEE7 #asco #2024asco #asco2024 #tigermed #clinicaltrials #chicago

Tigermed was honored to host a cross-country visit on the "New Horizon of Drug Development Innovation Forum" focusing on enhancing clinical research collaborations between China and South Korea on May 17th, 2024. In partnership with KoNECT (Korea National Enterprise for Clinical Trials) and DreamCIS, we were thrilled to welcome delegates from JW, Samsung, Shin Poog, Boryung, Daewoong, Kwangdong, Genuonesciences, CKD BiO and other South Korean top pharmaceuticals. The gathering represented a diverse range of perspectives, bringing together prominent researchers and industry experts to share the latest developments in the field.